Nordkin M, Fadaos N, Leiba R, Sharon-Horesh N, et al. Duration of anti-CD20 monoclonal antibody maintenance positively correlates with clinical outcomes in follicular lymphoma patients, supporting adherence to the recommended 2-year maintenance paradigm. Br J Haematol 2025;207:1104-1107.
PMID: 40954124